The effect of serial administration of bicarbonate on plasma total CO concentrations in horses.

Drug Test Anal

Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Werribee, Victoria, Australia.

Published: February 2021

AI Article Synopsis

  • The use of alkalinising agents like sodium bicarbonate in horses raises concerns for racing authorities due to potential performance enhancement and drug detection issues.
  • A study administering sodium bicarbonate and an electrolyte complex over three days to Standardbred horses showed that while plasma total carbon dioxide levels peaked after the first dose, they did not accumulate significantly with repeated dosing.
  • The findings suggest that multiple doses of sodium bicarbonate do not lead to sustained increases in plasma TCO levels beyond those reached after a single dose.

Article Abstract

The administration of alkalinising agents including bicarbonate is of concern to racing authorities because resultant alkalosis may enhance performance and interfere with the detection of drugs in post-race urine. A threshold for total carbon dioxide (TCO ) of 36.0 mmol/L in plasma (with action limit of 37.0 mmol/L) has been set. Serial dosing of sodium bicarbonate has gained popularity in human athletes but has not been studied in horses previously. Sodium bicarbonate (200 g per horse) and 60 g of an electrolyte-vitamin complex was administered in 2-L water via nasogastric intubation to five Standardbred horses for three consecutive days (total dose bicarbonate 0.42 ± 0.02 g/kg). Serial blood samples were taken over Days 1-5, with the final day (5) intended to simulate a 'clear day', and TCO was analysed. Following the first bicarbonate administration, plasma TCO peaked at 6 h (34.8 ± 1.3 mmol/L), returning to baseline by 23 h. On Day 2, four out of the five horses showed a peak greater than 36.0 mmol/L (mean 37.0 ± 2.1 mmol/L). With daily repeated dosing, plasma TCO peaked progressively earlier, and by Day 3, the peak occurred at 2 h and concentrations declined more rapidly. On Days 4 and 5, TCO levels remained low (<32.1 mmol/L on Day 4 and between 27.0-31.2 mmol/L on Day 5). These studies demonstrate that serial dosing of a 'split dose' of sodium bicarbonate on three consecutive days does not result in the accumulation or carry-over of plasma TCO levels beyond the levels observed following a single dose.

Download full-text PDF

Source
http://dx.doi.org/10.1002/dta.2937DOI Listing

Publication Analysis

Top Keywords

360 mmol/l
8
370 mmol/l
8
sodium bicarbonate
8
plasma tco
8
tco peaked
8
bicarbonate
6
tco
5
mmol/l
5
serial administration
4
administration bicarbonate
4

Similar Publications

Genotype-Phenotype Correlation in Progressive External Ophthalmoplegia: Insights From a Retrospective Analysis.

Neuropathol Appl Neurobiol

February 2025

Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, Jinan, Shandong, China.

Background: Progressive external ophthalmoplegia (PEO) is a classic manifestation of mitochondrial disease. However, the link between its genetic characteristics and clinical presentations remains poorly investigated.

Methods: We analysed the clinical, pathological and genetic characteristics of a large cohort of patients with PEO, based on the type of their mtDNA variations.

View Article and Find Full Text PDF

Albumin corrected anion gap and clinical outcomes in elderly patients with acute kidney injury caused or accompanied by sepsis: a MIMIC-IV retrospective study.

Eur J Med Res

January 2025

Department of Emergency, Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, 313000, People's Republic of China.

Background: Elderly acute kidney injury (AKI) occurring in the intensive care unit (ICU), particularly when caused or accompanied by sepsis, is linked to extended hospital stays, increased mortality rates, heightened prevalence of chronic diseases, and diminished quality of life. This study primarily utilizes a comprehensive critical care database to examine the correlation of albumin corrected anion gap (ACAG) levels with short-term prognosis in elderly patients with AKI caused or accompanied by sepsis, thus assisting physicians in early identification of high-risk patients.

Methods: This study utilized data from the Medical Information Mart for Intensive Care IV (MIMIC-IV, v2.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the patterns of medication adherence among gout patients using allopurinol and how these patterns affect serum urate levels and clinical outcomes.
  • It finds that while occasional missed doses may not drastically impact urate control, consistently taking breaks of more than three days significantly lowers the likelihood of achieving adequate urate levels.
  • The research emphasizes the importance of understanding individual medication-taking habits to improve treatment outcomes for gout patients.
View Article and Find Full Text PDF

Glycemia reduction in type 2 diabetes-Hypoglycemia outcomes: A randomized clinical trial.

PLoS One

November 2024

Department of Biostatistics and Bioinformatics, Milken Institute of Public Health, The Biostatistics Center, The George Washington University, Rockville, MD, United States of America.

Article Synopsis
  • The study aimed to compare the risk of hypoglycemia among type 2 diabetes patients on metformin and adding one of four common therapies: glargine, glimepiride, liraglutide, or sitagliptin.
  • The trial included 5,047 participants, assessing severe hypoglycemia events and symptoms over an average of 5 years, with a per-protocol analysis of 4,830 who completed follow-ups.
  • Results showed that glimepiride had the highest incidence of severe hypoglycemia (1.3%), while liraglutide and sitagliptin had the lowest risks, indicating varying hypoglycemia likelihood based on the second medication added
View Article and Find Full Text PDF

Differentiating between an irrational versus a rational fear of hypoglycemia has treatment implications and presents significant challenge for clinicians facing patients with type 1 diabetes, illustrated in this case. A 39-year-old woman with autoimmune-positive insulin-dependent diabetes sought help to alleviate severe diabetes distress, and symptoms of depression and anxiety, associated with unpredictable drastic blood glucose drops. After exhausting conventional methods, she adopted a ketogenic diet (KD).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!